Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer.
Aged
Carcinoma, Squamous Cell
/ pathology
Combined Modality Therapy
Deglutition
/ physiology
Deglutition Disorders
/ physiopathology
Female
Follow-Up Studies
Humans
Male
Middle Aged
Oropharyngeal Neoplasms
/ pathology
Prognosis
Prospective Studies
Quality of Life
Recovery of Function
Survival Rate
Xerostomia
/ physiopathology
dysphagia
functional outcomes
oropharyngeal cancer
quality of life
radiotherapy
saliva
shoulder function
transoral robotic surgery
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
15
07
2020
revised:
27
09
2020
accepted:
22
10
2020
pubmed:
6
12
2020
medline:
20
7
2021
entrez:
5
12
2020
Statut:
ppublish
Résumé
Functional and QoL outcomes were compared longitudinally in a cohort of patients treated for oropharyngeal squamous cell carcinoma (OPSCC) with primary transoral robotic surgery (TORS) or radiotherapy (RT). Forty-four patients undergoing primary TORS (n = 31) or RT (n = 13) for any stage OPSCC were included. Only low-stage disease was treated with TORS. Functional outcomes were: salivary flow rate, image-based swallowing function, and a self-reported 10-point scale comparing current swallowing function to baseline (CvB scale). QoL was assessed with European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30), Head & Neck Module (EORTC QLQ-HN35), and MD Anderson Dysphagia Inventory (MDADI). Shoulder impairment was assessed with Neck Dissection Impairment Index (NDII) and Oxford Shoulder Score (OSS). In the RT group, salivary flow rates had significantly declined at 12-month follow-up, with the biggest declines in QoL subscale scores recorded in the RT group for dry mouth and sticky saliva. Swallowing function on imaging studies was overall good, with no severe dysphagia within 1 year although, both treatment groups showed significant deterioration relative to baseline at the 12-month follow-up with increased DIGEST scores and pharyngeal retention. Shoulder impairment was rare at 1 year in both groups. A comprehensive examination of this cohort treated for OPSCC showed overall good functional and QoL outcomes 1 year after treatment. However, persistent impairment was seen in both groups with regards to swallowing function. In the TORS group, at 12-months follow-up, the QoL questionnaires showed worse scores in only one subscale (sticky saliva).
Identifiants
pubmed: 33277795
doi: 10.1002/cam4.3599
pmc: PMC7877346
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
483-495Informations de copyright
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
JAMA Otolaryngol Head Neck Surg. 2019 Sep 26;:
pubmed: 31556933
Br J Oral Maxillofac Surg. 2012 Mar;50(2):102-8
pubmed: 21742422
Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):628-34
pubmed: 22801885
Laryngoscope. 2016 May;126(5):1108-13
pubmed: 26542529
J Intern Med. 2020 Feb;287(2):134-152
pubmed: 31733108
Cancer. 2020 Apr 1;126(7):1492-1501
pubmed: 31873950
Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):870-6
pubmed: 11448365
Lancet Oncol. 2019 Oct;20(10):1349-1359
pubmed: 31416685
Eur J Cancer. 2020 Jul;134:52-59
pubmed: 32460181
Cancer. 2007 Jul 1;110(1):196-202
pubmed: 17546575
Laryngoscope. 2014 Sep;124(9):2096-102
pubmed: 24729006
Arch Otolaryngol Head Neck Surg. 2002 Jan;128(1):44-9
pubmed: 11784253
Dysphagia. 2017 Aug;32(4):472-479
pubmed: 28271296
Cancer. 2017 Jan 1;123(1):62-70
pubmed: 27564246
Head Neck. 2019 Feb;41(2):322-328
pubmed: 30552845
Dysphagia. 2015 Oct;30(5):521-8
pubmed: 26050238
Front Oncol. 2019 Oct 01;9:936
pubmed: 31632901
Laryngoscope. 2020 Feb;130(2):E48-E56
pubmed: 30919470
J Dent Res. 1987 Feb;66 Spec No:648-53
pubmed: 3476629
JAMA Otolaryngol Head Neck Surg. 2016 Jul 1;142(7):691-7
pubmed: 27347780